Remdesivir
Remdesivir is a prodrug of an adenosine triphosphate (ATP) analog, with potential antiviral activity against a variety of RNA viruses. Substrate of CES1 and inhibitor of CES2. Remdesivir, the first COVID-19 drug granted the full approval by the FDA
General
Type : Pro-Drug,Drug,Not A\/B H target,Propionate,Triazine
Chemical_Nomenclature : 2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate
Canonical SMILES : CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4
InChI : InChI=1S\/C27H35N6O8P\/c1-4-18(5-2)13-38-26(36)17(3)32-42(37,41-19-9-7-6-8-10-19)39-14-21-23(34)24(35)27(15-28,40-21)22-12-11-20-25(29)30-16-31-33(20)22\/h6-12,16-18,21,23-24,34-35H,4-5,13-14H2,1-3H3,(H,32,37)(H2,29,30,31)\/t17-,21+,23+,24+,27-,42-\/m0\/s1
InChIKey : RWWYLEGWBNMMLJ-YSOARWBDSA-N
Other name(s) : 3QKI37EEHE,GS 5734,GS-5734,CHEMBL4065616,SCHEMBL17712225,CHEBI:145994
MW : 602.6
Formula : C27H35N6O8P
CAS_number : 1809249-37-3
PubChem : 121304016
UniChem : RWWYLEGWBNMMLJ-YSOARWBDSA-N
IUPHAR :
Wikipedia :
Target
Families : Remdesivir ligand of proteins in family: Carb_B_Chordata
Stucture :
Protein : human-CES2 || human-CES1
References (11)
| Title : Plasma Protein Binding Determination for Unstable Ester Prodrugs: Remdesivir and Tenofovir Alafenamide - Wen_2023_J.Pharm.Sci__ |
| Author(s) : Wen A , Qin AR , Tarnowski T , Ling KHJ , Zhang H , Humeniuk R , Regan S , Saquing J , Liu W , Venkatarangan L , Xiao D |
| Ref : J Pharm Sci , : , 2023 |
| Abstract : Wen_2023_J.Pharm.Sci__ |
| ESTHER : Wen_2023_J.Pharm.Sci__ |
| PubMedSearch : Wen_2023_J.Pharm.Sci__ |
| PubMedID: 37722451 |
| Title : In vitro evaluation of the impact of Covid-19 therapeutic agents on the hydrolysis of the antiviral prodrug remdesivir - Zhang_2022_Chem.Biol.Interact_365_110097 |
| Author(s) : Zhang Q , Melchert PW , Markowitz JS |
| Ref : Chemico-Biological Interactions , 365 :110097 , 2022 |
| Abstract : Zhang_2022_Chem.Biol.Interact_365_110097 |
| ESTHER : Zhang_2022_Chem.Biol.Interact_365_110097 |
| PubMedSearch : Zhang_2022_Chem.Biol.Interact_365_110097 |
| PubMedID: 35964681 |
| Title : Human carboxylesterase 1A plays a predominant role in the hydrolytic activation of remdesivir in humans - Zhang_2021_Chem.Biol.Interact_351_109744 |
| Author(s) : Zhang F , Li HX , Zhang TT , Xiong Y , Wang HN , Lu ZH , Xiong L , He YQ , Ge GB |
| Ref : Chemico-Biological Interactions , 351 :109744 , 2021 |
| Abstract : Zhang_2021_Chem.Biol.Interact_351_109744 |
| ESTHER : Zhang_2021_Chem.Biol.Interact_351_109744 |
| PubMedSearch : Zhang_2021_Chem.Biol.Interact_351_109744 |
| PubMedID: 34774545 |
| Gene_locus related to this paper: human-CES1 |
| Title : Remdesivir potently inhibits carboxylesterase-2 through covalent modifications: signifying strong drug-drug interactions - Shen_2021_Fundam.Clin.Pharmacol_35_432 |
| Author(s) : Shen Y , Eades W , Yan B |
| Ref : Fundamental & Clinical Toxicology , 35 :432 , 2021 |
| Abstract : Shen_2021_Fundam.Clin.Pharmacol_35_432 |
| ESTHER : Shen_2021_Fundam.Clin.Pharmacol_35_432 |
| PubMedSearch : Shen_2021_Fundam.Clin.Pharmacol_35_432 |
| PubMedID: 33369768 |
| Gene_locus related to this paper: human-CES2 |
| Title : Key Metabolic Enzymes Involved in Remdesivir Activation in Human Lung Cells - Li_2021_Antimicrob.Agents.Chemother__AAC0060221 |
| Author(s) : Li R , Liclican A , Xu Y , Pitts J , Niu C , Zhang J , Kim C , Zhao X , Soohoo D , Babusis D , Yue Q , Ma B , Murray BP , Subramanian R , Xie X , Zou J , Bilello JP , Li L , Schultz BE , Sakowicz R , Smith BJ , Shi PY , Murakami E , Feng JY |
| Ref : Antimicrobial Agents & Chemotherapy , :AAC0060221 , 2021 |
| Abstract : Li_2021_Antimicrob.Agents.Chemother__AAC0060221 |
| ESTHER : Li_2021_Antimicrob.Agents.Chemother__AAC0060221 |
| PubMedSearch : Li_2021_Antimicrob.Agents.Chemother__AAC0060221 |
| PubMedID: 34125594 |
| Title : Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside - Tao_2021_Curr.Res.Pharmacol.Drug.Discov_2_100045 |
| Author(s) : Tao S , Zandi K , Bassit L , Ong YT , Verma K , Liu P , Downs-Bowen JA , McBrayer T , LeCher JC , Kohler JJ , Tedbury PR , Kim B , Amblard F , Sarafianos SG , Schinazi RF |
| Ref : Curr Res Pharmacol Drug Discov , 2 :100045 , 2021 |
| Abstract : Tao_2021_Curr.Res.Pharmacol.Drug.Discov_2_100045 |
| ESTHER : Tao_2021_Curr.Res.Pharmacol.Drug.Discov_2_100045 |
| PubMedSearch : Tao_2021_Curr.Res.Pharmacol.Drug.Discov_2_100045 |
| PubMedID: 34870151 |
| Title : The COVID-19 medicine remdesivir is therapeutically activated by carboxylesterase-1 AND excessive hydrolysis increases cytotoxicity - Shen_2021_Hepatol.Commun__ |
| Author(s) : Shen Y , Eades W , Yan B |
| Ref : Hepatol Commun , : , 2021 |
| Abstract : Shen_2021_Hepatol.Commun__ |
| ESTHER : Shen_2021_Hepatol.Commun__ |
| PubMedSearch : Shen_2021_Hepatol.Commun__ |
| PubMedID: 34230903 |
| Title : ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential - Deb_2021_Pharmaceuticals.(Basel)_14_ |
| Author(s) : Deb S , Reeves AA , Hopefl R , Bejusca R |
| Ref : Pharmaceuticals (Basel) , 14 : , 2021 |
| Abstract : Deb_2021_Pharmaceuticals.(Basel)_14_ |
| ESTHER : Deb_2021_Pharmaceuticals.(Basel)_14_ |
| PubMedSearch : Deb_2021_Pharmaceuticals.(Basel)_14_ |
| PubMedID: 34358081 |
| Title : Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19 - Eastman_2020_ACS.Cent.Sci_6_672 |
| Author(s) : Eastman RT , Roth JS , Brimacombe KR , Simeonov A , Shen M , Patnaik S , Hall MD |
| Ref : ACS Cent Sci , 6 :672 , 2020 |
| Abstract : Eastman_2020_ACS.Cent.Sci_6_672 |
| ESTHER : Eastman_2020_ACS.Cent.Sci_6_672 |
| PubMedSearch : Eastman_2020_ACS.Cent.Sci_6_672 |
| PubMedID: 32483554 |
| Title : Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease - Agostini_2018_mBio_9_ |
| Author(s) : Agostini ML , Andres EL , Sims AC , Graham RL , Sheahan TP , Lu X , Smith EC , Case JB , Feng JY , Jordan R , Ray AS , Cihlar T , Siegel D , Mackman RL , Clarke MO , Baric RS , Denison MR |
| Ref : MBio , 9 : , 2018 |
| Abstract : Agostini_2018_mBio_9_ |
| ESTHER : Agostini_2018_mBio_9_ |
| PubMedSearch : Agostini_2018_mBio_9_ |
| PubMedID: 29511076 |